Procymate
Chemical compound
Clinical data | |
---|---|
Routes of administration | By mouth |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C10H19NO2 |
Molar mass | 185.267 g·mol−1 |
3D model (JSmol) |
|
| |
| |
NY (what is this?) (verify) |
Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.
References
- ^ "Procymate". Bank of Automated Data on Drugs. VIDAL Drug Database. Archived from the original on 12 January 2008.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
Retrieved from "https://en.wikipedia.org/w/index.php?title=Procymate&oldid=1197443147"